title: Stabilization of multiple metastatic epithelioid sarcoma under treatment with sunitinib malate.
authors.forename: P
authors.initials: P
authors.lastname: Penot
authors.forename: J-D
authors.initials: JD
authors.lastname: Bouaziz
authors.forename: M
authors.initials: M
authors.lastname: Battistella
authors.forename: D
authors.initials: D
authors.lastname: Kerob
authors.forename: C
authors.initials: C
authors.lastname: Pagès
authors.forename: C
authors.initials: C
authors.lastname: Vilmer
authors.forename: N
authors.initials: N
authors.lastname: Basset-Seguin
authors.forename: N
authors.initials: N
authors.lastname: Madjessli
authors.forename: C
authors.initials: C
authors.lastname: Comte
authors.forename: C
authors.initials: C
authors.lastname: Farges
authors.forename: M
authors.initials: M
authors.lastname: Bagot
authors.forename: C
authors.initials: C
authors.lastname: le Maignan
authors.forename: C
authors.initials: C
authors.lastname: Lebbé
mesh_terms: D000328:Adult; D000671:Amputation, Surgical; D000672:Amputation Stumps; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001365:Axilla; D004334:Drug Administration Schedule; D005542:Forearm; D006225:Hand; D006801:Humans; D007211:Indoles / Q000008:administration & dosage*; D008297:Male; D019042:Muscle Neoplasms / Q000188:drug therapy / Q000556:secondary; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D011758:Pyrroles / Q000008:administration & dosage*; D012509:Sarcoma / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery; D000077210:Sunitinib; D016896:Treatment Outcome; D014472:Umbilicus
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib